Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference41 articles.
1. Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era;Huang;Ann Hematol,2013
2. Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab;Czuczman;Leuk Lymphoma,2006
3. The revised International Prognostic Index (RIPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP;Sehn;Blood,2007
4. NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas;Zelenetz;J Natl Compr Cancer Netw,2010
5. Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story;Bari;Ann Oncol,2010
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessment of Left Ventricular Diastolic Function in Patients with Diffuse LargeB-cell Lymphoma after Anthracycline Chemotherapy by using Vector FlowMapping;Current Medical Imaging Reviews;2024-07-24
2. Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment;Cancers;2023-08-15
3. Mitochondrial Peptide Humanin Facilitates Chemoresistance in Glioblastoma Cells;Cancers;2023-08-11
4. PD‐L1 expression predicts efficacy in the phase II SPiReL trial with MVP‐S, pembrolizumab, and low‐dose CPA in R/R DLBCL;European Journal of Haematology;2023-05-08
5. Prognostic value of FOXP3+ regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis;BMJ Open;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3